About Bevacizumab
            
            Class: | Monoclonal antibody (VEGF inhibitor)  
Use: | Treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and cervical cancer, among others.  
Adult dose: | 5 mg/kg IV every 2 weeks or 10 mg/kg IV every 2 weeks, depending on the specific indication and in combination with chemotherapy.  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is generally not recommended.  
Side effects: | Hy
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (VEGF inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and cervical cancer, among others.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: F. Hoffmann-La Roche Ltd., SWITZERLAND
                    
                    
                    Package Size
                    4ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2767.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        5 mg/kg IV every 2 weeks or 10 mg/kg IV every 2 weeks, depending on the specific indication and in combination with chemotherapy.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is generally not recommended.
                    
                 
                
                
                    
                        Side Effects
                    
                    Hypertension, fatigue, headache, gastrointestinal perforations, proteinuria, bleeding complications, and infusion reactions.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to bevacizumab or any component of the formulation; recent surgery or wound healing complications; history of hemoptysis; and pregnancy.
         
        
        
            
                Important Warnings
            
            Risk of serious bleeding, gastrointestinal perforations, and impaired wound healing; monitor for hypertension and proteinuria; not recommended during pregnancy or breastfeeding.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.